These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2426174)

  • 41. Current trends in therapy of ocular herpes simplex: experimental and clinical studies.
    Pavan-Langston D
    Adv Ophthalmol; 1979; 38():82-8. PubMed ID: 93409
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C; Rougier P; Bizollon T; Poupon R; Zarski JP; Quinton A; Miguet JP; Causse X; Chossegros P; Chevallier M
    J Hepatol; 1991; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract]   [Full Text] [Related]  

  • 43. Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
    Weiss GB; Metch B; Von Hoff DD; Taylor SA; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1313-4. PubMed ID: 2446753
    [No Abstract]   [Full Text] [Related]  

  • 44. Responses of patients to arabinosyladenine-5'-phosphate correlated with an in vitro test.
    Lepage GA; Khaliq A
    Adv Enzyme Regul; 1978; 17():437-54. PubMed ID: 93404
    [No Abstract]   [Full Text] [Related]  

  • 45. [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
    Ouzan D
    Rev Prat; 1992 Jun; 42(11):1383-6. PubMed ID: 1382310
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
    Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
    Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy of herpes simplex virus encephalitis in mice by direct intracerebral injection.
    Cameron KR; Adams DH
    J Infect Dis; 1979 Dec; 140(6):921-6. PubMed ID: 94338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of fludarabine phosphate in patients with recurrent glioma.
    Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
    Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Beltran G; Saiers JH; Oishi N; Von Hoff DD
    Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482
    [No Abstract]   [Full Text] [Related]  

  • 52. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Von Hoff DD; Katterhagen JG; Coltman CA
    Cancer Treat Rep; 1987 Dec; 71(12):1319-20. PubMed ID: 2446754
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
    Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
    [No Abstract]   [Full Text] [Related]  

  • 55. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Suppression of bone marrow in neonatal herpes simplex virus infection under virustatic therapy with adenine arabinoside-5'-monophosphate (author's transl)].
    Ebell W; Borchard F; Knoll G; von Voss H
    Klin Padiatr; 1980 Nov; 192(6):582-6. PubMed ID: 6163882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and neurotoxicity of ARA-AMP in CAH-B.
    Lok A
    Hepatology; 1990 Apr; 11(4):713. PubMed ID: 1691734
    [No Abstract]   [Full Text] [Related]  

  • 60. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.